| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1921137 | Parkinsonism & Related Disorders | 2010 | 4 Pages |
Abstract
In this large survey, a substantial proportion of ET patients failed treatment with both front-line medications. Among patients seeing movement disorder specialists, the number of medications they had had to try was sizable. These data demonstrate the limitations of current pharmacological options for ET.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Nancy L. Diaz, Elan D. Louis,